Research Nester Logo.jpg
Non-Hodgkin Lymphoma Therapeutics Market revenue to hit USD 20 Billion by 2036, says Research Nester
March 19, 2024 07:00 ET | Research Nester
New York , March 19, 2024 (GLOBE NEWSWIRE) -- The global non-hodgkin lymphoma therapeutics market size is projected to grow at a CAGR of over 8% from 2024 to 2036. The market is expected to garner a...
Global Retinoblastoma Treatment Market
Global Retinoblastoma Treatment Market Set to Reach $4.20 Billion by 2034 with Steady Growth in Targeted Therapies and Gene Treatment
March 12, 2024 13:42 ET | Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Retinoblastoma Treatment Market" report has been added to ResearchAndMarkets.com's offering.The global retinoblastoma treatment market size...
Research Nester Logo.jpg
Neuroendocrine Tumor Treatment Market revenue to hit USD 8 Billion by 2035, says Research Nester
March 12, 2024 05:00 ET | Research Nester
New York, March 12, 2024 (GLOBE NEWSWIRE) -- The global neuroendocrine tumor treatment market size is slated to expand at ~12% CAGR between 2023 and 2035. The market is poised to garner a revenue of...
Global Kaposi Sarcoma Market
Global Kaposi Sarcoma Market Analysis 2024-2034: HAART Emerges as a Game-Changer in HIV Treatment, Paving the Way for Control and Prevention of AIDS-Associated Kaposi Sarcoma
March 11, 2024 13:46 ET | Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Kaposi Sarcoma Market by Type, by Treatment, by End-Users, and By Region" report has been added to ResearchAndMarkets.com's offering. The...
Global Chemotherapy Induced Peripheral Neuropathy Treatment Market
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, Featuring Sanofi, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical and Amgen
March 08, 2024 04:28 ET | Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The chemotherapy...
22157.jpg
Global PRMT5 Targeted Therapy Market & Clinical Trials Insights 2024: Innovation and Potential in Oncology and Beyond
February 29, 2024 04:06 ET | Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024" report has been added to ResearchAndMarkets.com's offering. ...
Chinese Oncology Drugs Market
China Oncology Drugs Market Report, 2023 and 2024-2028 - Cancer Prevention Takes Center Stage in China's National Health Agenda
February 19, 2024 07:48 ET | Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "China Oncology Drugs Market, Size, Forecast 2024-2028, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been...
Global Head and Neck Cancer Therapeutics Market
Head and Neck Cancer Therapeutics Market to Reach $2.3 Billion by 2027 - New Research Report Reveals
January 24, 2024 13:26 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Head and Neck Cancer Therapeutics Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The latest research report...
22157.jpg
Global Thyroid Cancer Drugs Market Report 2024: Highlights Trends in Targeted Therapies, Featuring Profiles of Mylan Pharmaceuticals, AstraZeneca, Exelixis, Pfizer, and Bristol-Myers Squibb
January 23, 2024 15:28 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Global Market 2024" report has been added to ResearchAndMarkets.com's offering. The global thyroid cancer drugs market...
Global Chemotherapy Induced Peripheral Neuropathy Market
Chemotherapy Induced Peripheral Neuropathy Treatment Market to Surge to $2.06 Billion by 2027, New Research Shows
January 23, 2024 02:38 ET | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The...